Related Experiment Video

Updated: Dec 13, 2025

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

15.0K

BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis

John J Krais1, Neil Johnson2

  • 1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Cancer Research
|August 5, 2020
PubMed

Insights

Cancers with BRCA1 mutations lose homologous recombination (HR) DNA repair, making them vulnerable to certain therapies. However, tumors can regain HR proficiency, leading to treatment resistance.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Biology

Background:

  • Cancers with germline BRCA1 mutations exhibit homologous recombination (HR) DNA repair deficiency.
  • This deficiency confers sensitivity to DNA-damaging agents like platinum and PARP inhibitors.
  • Loss of HR is typically lethal in vertebrates, necessitating compensatory mechanisms in cancer cells.

Purpose of the Study:

  • To review the biological mechanisms enabling HR in BRCA1-mutant cancers.
  • To examine how HR status changes during cancer progression and therapy.
  • To understand the transition to HR proficiency and therapy resistance.

Main Methods:

  • Review of existing literature on BRCA1, HR DNA repair, and cancer therapy.
  • Analysis of genetic adaptations enabling HR proficiency in cancer.
  • Discussion of HR status fluctuations throughout the cancer life course.

Main Results:

  • BRCA1-mutant cancers develop strategies to compensate for HR deficiency.
  • Tumor evolution under chemotherapy pressure can lead to a shift towards HR proficiency.
  • HR status is dynamic, influencing response to treatment and development of resistance.

Conclusions:

  • Understanding HR mechanisms in BRCA1-mutant cancers is crucial for effective treatment strategies.
  • The plasticity of HR status contributes to therapy resistance in these cancers.
  • Further research into HR regulation can inform the development of novel therapeutic approaches.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.5K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.8K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.3K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.1K
Mismatch Repair01:36

Mismatch Repair

Overview
43.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.7K